RAPT Therapeutics Inc. company and executive profile by Barron's. View the latest RAPT company infomation and executive bios.

STANDALONE PERFORMANCE At the end of 2022-23, our standalone turnover declined by 13.48% to touch Rs.335.70 Crore, which was Rs.388.03 Crore in 2021-22.